Literature DB >> 17622567

Acetyl-L-carnitine and alpha-lipoic acid supplementation of aged beagle dogs improves learning in two landmark discrimination tests.

N W Milgram1, J A Araujo, T M Hagen, B V Treadwell, B N Ames.   

Abstract

Beagle dogs between 7.6 and 8.8 years of age administered a twice daily supplement of alpha-lipoic acid (LA) and acetyl-L-carnitine (ALC) over approximately 2 months made significantly fewer errors in reaching the learning criterion on two landmark discrimination tasks compared to controls administered a methylcellulose placebo. Testing started after a 5 day wash-in. The dogs were also tested on a variable delay version of a previously acquired spatial memory task; results were not significant. The improved performance on the landmark task of dogs supplemented with LA + ALC provides evidence of the effectiveness of this supplement in improving discrimination and allocentric spatial learning. We suggest that long-term maintenance on LA and ALC may be effective in attenuating age-associated cognitive decline by slowing the rate of mitochondrial decay and cellular aging.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17622567     DOI: 10.1096/fj.07-8531com

Source DB:  PubMed          Journal:  FASEB J        ISSN: 0892-6638            Impact factor:   5.191


  18 in total

1.  Evidence that α-lipoic acid inhibits NF-κB activation independent of its antioxidant function.

Authors:  Zhekang Ying; Thomas Kampfrath; Qinghua Sun; Sampath Parthasarathy; Sanjay Rajagopalan
Journal:  Inflamm Res       Date:  2010-10-07       Impact factor: 4.575

Review 2.  Reactive oxygen species in the regulation of synaptic plasticity and memory.

Authors:  Cynthia A Massaad; Eric Klann
Journal:  Antioxid Redox Signal       Date:  2010-10-28       Impact factor: 8.401

3.  Age-related defects in short-term plasticity are reversed by acetyl-L-carnitine at the mouse calyx of Held.

Authors:  Mahendra Singh; Pedro Miura; Robert Renden
Journal:  Neurobiol Aging       Date:  2018-03-21       Impact factor: 4.673

Review 4.  Mitochondria as chi.

Authors:  Douglas C Wallace
Journal:  Genetics       Date:  2008-06       Impact factor: 4.562

Review 5.  Novel therapeutics for Alzheimer's disease: an update.

Authors:  David J Bonda; Hyun-Pil Lee; Hyoung-gon Lee; Avi L Friedlich; George Perry; Xiongwei Zhu; Mark A Smith
Journal:  Curr Opin Drug Discov Devel       Date:  2010-03

6.  Lessons learnt from animal models: pathophysiology of neuropathic lysosomal storage disorders.

Authors:  Kim M Hemsley; John J Hopwood
Journal:  J Inherit Metab Dis       Date:  2010-05-07       Impact factor: 4.982

Review 7.  Mitochondrial dynamics in Alzheimer's disease: opportunities for future treatment strategies.

Authors:  David J Bonda; Xinglong Wang; George Perry; Mark A Smith; Xiongwei Zhu
Journal:  Drugs Aging       Date:  2010-03-01       Impact factor: 3.923

8.  Mitochondrial Dysfunction during Brain Aging: Role of Oxidative Stress and Modulation by Antioxidant Supplementation.

Authors:  Sasanka Chakrabarti; Soumyabrata Munshi; Kalpita Banerjee; Ishita Guha Thakurta; Maitrayee Sinha; Maria Bindu Bagh
Journal:  Aging Dis       Date:  2011-03-23       Impact factor: 6.745

9.  Alpha-lipoic acid induces elevated S-adenosylhomocysteine and depletes S-adenosylmethionine.

Authors:  Sally P Stabler; Jeevan Sekhar; Robert H Allen; Heidi C O'Neill; Carl W White
Journal:  Free Radic Biol Med       Date:  2009-07-17       Impact factor: 7.376

Review 10.  Cellular stress response: a novel target for chemoprevention and nutritional neuroprotection in aging, neurodegenerative disorders and longevity.

Authors:  Vittorio Calabrese; Carolin Cornelius; Cesare Mancuso; Giovanni Pennisi; Stella Calafato; Francesco Bellia; Timothy E Bates; Anna Maria Giuffrida Stella; Tony Schapira; Albena T Dinkova Kostova; Enrico Rizzarelli
Journal:  Neurochem Res       Date:  2008-07-16       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.